Allarity Therapeutics, Inc. Stock Analysis & AI Score
Allarity Therapeutics, Inc. (ALLR) has an ST Score of 19.6 (D), driven by its Momentum (C-) and held back by its Financial Strength (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Allarity Therapeutics, Inc. (ALLR) has an ST Score of 19.6 (D), driven by its Momentum (C-) and held back by its Financial Strength (F). Analysts rate it Buy.
- Strongest
- MomentumC-
- Weakest
- Financial StrengthF
All factor grades
- MomentumC-
- GrowthC-
- ValuationD+
- ProfitabilityD
- Financial StrengthF
- Piotroski1/9
Contact
ALLR stock: frequently asked questions
What is ALLR's ST Score?
Allarity Therapeutics, Inc. (ALLR) has an ST Score of 19.6 (D), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ALLR a buy, hold, or sell?
Analysts rate ALLR a Buy. Our ST Score grades it D (19.6/100). The ST Score is a data-driven signal, not a recommendation.
What are ALLR's factor grades?
Valuation D+, Profitability D, Financial Strength F, Momentum C-, Growth C-.
What is ALLR's valuation grade?
Allarity Therapeutics, Inc. (ALLR) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ALLR's growth grade?
Allarity Therapeutics, Inc. (ALLR) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ALLR's profitability grade?
Allarity Therapeutics, Inc. (ALLR) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ALLR's financial strength grade?
Allarity Therapeutics, Inc. (ALLR) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is ALLR's Piotroski score?
Allarity Therapeutics, Inc. (ALLR) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.